Impact of the COVID-19 pandemic on surgical care in the Netherlands
Michelle R. de Graaff(Dutch Institute for Clinical Auditing), Koen J. Hartemink(Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital), Arthur K.E. Elfrink(Amsterdam University Medical Centers), Henderik L. van Westreenen(Isala), Emiel G. G. Verdaasdonk(Jeroen Bosch Ziekenhuis), Marc G. Besselink(Amsterdam Neuroscience), Mark I. van Berge Henegouwen(University of Namur), Jean‐Paul P.M. de Vries(University Medical Center Groningen), Jan-Willem Elshof(VieCuri Medisch Centrum), Jarno Melenhorst(Maastricht University Medical Centre), Peter van Duijvendijk(Gelre Hospitals), Joost A.B. van der Hoeven, G M H Marres(University Medical Center Groningen), Schelto Kruijff(University Medical Center Groningen), Erman O. Akpinar(Maastricht University), Nienke Wolfhagen(Radboud University Nijmegen), Daan M. Voeten(Dutch Institute for Clinical Auditing), Mark van Heijl(University Medical Center Utrecht), Yester F. Janssen(University Medical Center Groningen), Suzanne S. Gisbertz(Dutch Cancer Society), Rianne N. M. Hogenbirk(University Medical Center Groningen), David J. Heineman(Amsterdam University Medical Centers), Anna J. Alberga(Amsterdam UMC Location Vrije Universiteit Amsterdam), C L Koningswoud-Terhoeve, E Belt(Gelre Hospitals), Ronald S. L. Liem(Nederlandse Obesitas Kliniek), J. Annelie Suurmeijer(Amsterdam University Medical Centers), Michel W.J.M. Wouters(The Netherlands Cancer Institute), Marcel den Dulk(Leiden University Medical Center), Joost M. Klaase(University Medical Center Groningen), Marieke J Bolster-van Eenennaam(Gelre Hospitals), Anne‐Loes K. Warps(University Medical Center Groningen), Franka S. Würdemann(Leiden University Medical Center), Simon W. Nienhuijs(Radboud University Nijmegen), Erik M. von Meyenfeldt(Albert Schweitzer Ziekenhuis), F Tozzi(Amsterdam University Medical Centers), Ron Balm(Amsterdam University Medical Centers), Wietse J. Eshuis(Dutch Cancer Society), Jelle P. Ruurda(University Medical Center Utrecht), Anne Loes van den Boom(University Medical Center Groningen), Arjen M. Rijken(Amphia Ziekenhuis), Freek Daams(Maine Farmland Trust), Johannes H. Hegeman(Ziekenhuis Groep Twente), C Dickhoff(Leiden University Medical Center), H. Reinier Zandbergen, R R J Coebergh-van den Braak, Jerry Braun(Leiden University), S Huisman(Leiden University Medical Center), J N Helleman
Cited by 24
Related Papers
Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer
|New England Journal of Medicine|2012|5.5k
Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial
|The Lancet Oncology|2015|2.6k
Definition and grading of anastomotic leakage following anterior resection of the rectum: A proposal by the International Study Group of Rectal Cancer
|Surgery|2009|1.5k
Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma
|New England Journal of Medicine|2017|1.4k